- Report
- March 2024
- 175 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- May 2024
- 193 Pages
Global
From €4760EUR$4,950USD£4,083GBP
- Report
- February 2024
- 175 Pages
Global
From €4808EUR$5,000USD£4,124GBP
- Report
- January 2024
- 182 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- November 2023
- 176 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- July 2023
- 225 Pages
Global
From €4327EUR$4,500USD£3,712GBP
- Report
- June 2020
- 464 Pages
Global
From €4712EUR$4,900USD£4,042GBP
- Report
- November 2018
- 281 Pages
Global
From €4760EUR$4,950USD£4,083GBP
- Report
- April 2023
- 112 Pages
Global
From €4567EUR$4,750USD£3,918GBP
- Report
- May 2022
- 324 Pages
Global
From €3462EUR$3,600USD£2,970GBP
- Report
- February 2024
- 132 Pages
Global
From €913EUR$950USD£784GBP
The Genotyping Assay market is a subset of the larger Genomics market, which focuses on the study of genetic material. Genotyping Assays are used to identify genetic variations in individuals, such as single nucleotide polymorphisms (SNPs) and copy number variations (CNVs). These assays are used in a variety of applications, including disease diagnosis, drug development, and forensic analysis. Genotyping Assays are typically performed using a variety of technologies, such as polymerase chain reaction (PCR), next-generation sequencing (NGS), and microarray-based assays.
Companies in the Genotyping Assay market include Illumina, Thermo Fisher Scientific, Agilent Technologies, QIAGEN, Bio-Rad Laboratories, and PerkinElmer. Show Less Read more
